Drug
Brivekimig clinical trials
Also written SAR442970.
- studies test it
- 6
- open now
- 3
- in phase 3
- 0
- first study started
- 2023
Keep track of what changes. Save the brivekimig studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
6 studies that test it; most in 2025 (4)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses brivekimig is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseRecruitingPhase 2SanofiNCT06500702Written as brivekimig
- A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's DiseaseRecruitingPhase 2SanofiNCT06958536Written as brivekimig
- Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaRecruitingPhase 2SanofiNCT07170917Written as Brivekimig
- A Study to Investigate the Efficacy and Safety of Brivekimig in Adult Participants With Ulcerative ColitisActive, not recruitingPhase 2SanofiNCT06975722Written as SAR442970
- Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® MoleculeActive, not recruitingPhase 2SanofiNCT06812988Written as Brivekimig
- A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis SuppurativaCompletedPhase 2SanofiNCT05849922Written as SAR442970
Codes
What other systems call brivekimig · ClinicalTrials.gg INT018510
- UNII (FDA) XX2BGT8CLLBRIVEKIMIGOne source FDA
- NCI Thesaurus C206890BrivekimigOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | XX2BGT8CLL | BRIVEKIMIG | One source FDA |
| NCI Thesaurus | C206890 | Brivekimig | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.